Skeletal muscle possesses regenerative capacity due to tissue-resident, muscle-fiber-generating (myogenic) satellite cells (SCs), which can form new muscle fibers under the right conditions. Although SCs can be harvested from muscle tissue and cultured in vitro, the resulting myoblast cells are not very effective in promoting myogenesis when transplanted into host muscle. Surgically exposing the host muscle and grafting segments of donor muscle tissue, or the isolated muscle fibers with their SCs onto host muscle, promotes better myogenesis compared to myoblast transplantation. We have developed a novel technique that we call Minimally Invasive Muscle Embedding (MIME). MIME involves passing a surgical needle through the host muscle, drawing a piece of donor muscle tissue through the needle track, and then leaving the donor tissue embedded in the host muscle so that it may act as a source of SCs for the host muscle. Here we describe in detail the steps involved in performing MIME in an immunodeficient mouse model that expresses a green fluorescent protein (GFP) in all of its cells. Immunodeficiency in the host mouse reduces the risk of immune rejection of the donor tissue, and GFP expression enables easy identification of the host muscle fibers (GFP+) and donor-cell-derived muscle fibers (GFP-). Our pilot data suggest that MIME can be used to implant an extensor digitorum longus (EDL) muscle from a donor mouse into the tibialis anterior (TA) muscle of a host mouse. Our data also suggest that when a myotoxin (barium chloride, BaCl 2 ) is injected into the host muscle after MIME, there is evidence of donor-cell-derived myogenesis in the host muscle, with approximately 5%, 26%, 26% and 43% of the fibers in a single host TA muscle showing no host contribution, minimal host contribution, moderate host contribution, and maximal host contribution, respectively.
Introduction
Healthy skeletal muscle, even though post-mitotic, possesses excellent regenerative capacity due to the presence of tissue-resident myogenic cells known as satellite cells (SCs) 1, 2 ; and reviewed in 3, 4 . However, under pathological conditions caused by muscular dystrophies, trauma or accelerated aging, the muscle regeneration might not keep up with muscle breakdown, and thus, progressive muscle fiber loss occurs 5 . Although effective methods have been developed to isolate SCs from muscle and expand them in culture to generate large numbers of myoblasts (and subsequently myotubes), attempts to generate physiologically relevant numbers of muscle fibers in host muscle have yielded only minimal success 6 . As with many other cell types, when myoblasts are injected alone into host tissue, most of the cells do not engraft 7, 8 . We have shown that neuromuscular electrical stimulation (NMES) facilitates donor-cell-derived myogenesis in regeneration-deficient host mouse muscle that was injected with human myoblasts 8 . Others have demonstrated that surgically grafting biopsied muscle or single muscle fibers with attached SCs, facilitate moderate myogenesis even without NMES, suggesting that implanting whole muscle fibers with SCs might be more advantageous than implanting myogenic cells alone 9, 10 . Since donor or engineered muscle tissue grafted into host muscle produces better results than transplanting cells alone, it is possible that tissue or tissue-like structures might provide crucial cues for donor-cell engraftment; a concept which is becoming increasingly evident in cell-therapy studies involving various cell types 10, 11, 12 .
Recent data suggest that SCs obtained from humans more than 2 weeks post mortem generate myotubes in culture 13 . We therefore intend to assess if implantation of muscle tissue harvested post-mortem into a living host will reverse muscle fiber loss. We have developed a novel technique called MIME to implant donor muscle tissue into skeletal muscle tissue of a living host in order to promote donor-cell-derived myogenesis. MIME involves passing a surgical needle through the host muscle to create a needle track; drawing a small segment of donor muscle tissue through the needle track; leaving the donor tissue embedded in the host muscle; and closing the needle holes with tissue adhesive. After practicing the technique in euthanized mice studied in other experiments, we have now performed MIME in live mice that are immunodeficient and ubiquitously express a green fluorescent protein (GFP), and follow-up at 3 and 14 days post-MIME. At 3 days post-MIME, we confirm that donor mouse (GFP-) EDL muscle implanted into host mouse (GFP+) TA muscle, remains embedded in the host muscle. At 14 days post-MIME, after BaCl 2 myotoxin injury to induce damage and myogenesis, we confirm that approximately 5%, 26%, 26% and 43% of the fibers in a single host TA muscle show no host contribution, minimal host contribution, moderate host contribution, and maximal host contribution,
Animal Models
1. Host mice for MIME 1. Use NSG-GFP mice (8 -10 week, male) as hosts for the muscle grafts studies. NOTE: These mice are ideal hosts for allogeneic muscle grafts because they lack mature T and B lymphocytes and functional natural killer cells, are deficient in cytokine signaling, and have been used by others for allografting or xenografting non-muscle cells 14 . Ubiquitous GFP expression allows for easy identification of host (GFP+) and donor-cell-derived (GFP-) muscle fibers.
2. Donor mice for MIME 1. Use C57BL/6J mice (12 -16 week) as donor mice. NOTE: These mice are suitable donor mice because they have a fully mapped genome, are not known to have any skeletal muscle pathology, are easily available and economical, and do not express GFP.
Preparing Donor Muscle Tissue
1. Tying Guiding Sutures and Harvesting donor EDL muscles 1. Euthanize the donor mice by cervical dislocation and thoracotomy performed under general anesthesia administered by a tabletop isoflurane vaporizer driven by medical oxygen (inhaled isoflurane; 2 -5% to effect). 2. To access the EDL muscles, use a pair of surgical scissors to open the skin over the anterior surface of the leg. Locate the TA muscle in the anterior leg and remove it to visualize the EDL muscle that is situated behind the TA muscle. Slide the tip of a pair of forceps behind the EDL muscle and apply gentle traction to see if the toes extend (this confirms that the muscle is the EDL). NOTE: Donor tissue area should be surgically, aseptically prepped prior to harvest. 3. Use ~ 10 cm segments of 4-0 silk, braided, non-absorbable, sterile suture, and make two double knots to apply the guiding sutures to the proximal and distal tendons of the EDL muscle. (Figure 1A ). 4. Cut the distal EDL tendon, reflect the EDL muscle and cut the proximal tendon. 5. Place the donor EDL muscles in a Petri dish filled with mouse Ringer solution.
Preparing Host Mice for MIME
1. Anesthesia 1. Place the host mouse under general anesthesia (inhaled isoflurane; 1.5 -5% to effect) administered by a tabletop isoflurane vaporizer driven by medical oxygen. 2. Induce anesthesia in an induction chamber and then transfer the mouse to a nose-cone to maintain the anesthesia while performing other procedures on the animal. Provide thermal support with an isothermal gel heating pad while the animal is under anesthesia.
2. Skin preparation 1. To remove the animal's fur, apply a depilatory cream over the anterior aspect of the left hind leg. The right leg serves as a control leg for subsequent procedures. 2. Leave the depilatory cream on for 2 min. Clean off the depilatory cream along with the detached fur with wipes soaked in phosphate buffered saline (PBS). After fur removal, scrub the skin with three alternating wipes of povidone-iodine scrubbing solution and 70 % ethanol.
Representative Results
At 3 days post-MIME, the donor EDL that is implanted by MIME is contained within the host TA muscle compartment (Figure 2A-C) . As expected, the cross sections of the TA muscle from donor mice, studied under fluorescence optics, do not show green fluorescence because they do not express GFP ( Figure 2D) . In contrast, the cross sections of the TA muscle from host mice that are not implanted with donor tissue, show uniform green fluorescence in the TA muscle fibers, as the fibers express GFP (Figure 2E ). In the cross sections of muscles implanted by MIME with donor muscle tissue, there is a line of demarcation between the host muscle fibers (GFP+) and donor muscle fibers (GFP-). The phase contrast images of the visual fields shown in Figure 2D -F are presented in Figure 2E '-F' and suggest that there are indeed muscle fibers present in the regions where there is no GFP signal.
At 14 days post-MIME and BaCl 2 injection, by studying serial cross sections of the TA muscle that are left unlabeled or are labeled with antibodies to desmin (Figure 3) , we learn that the GFP signal is expressed by all the muscle fibers in the untreated muscle from host mice, but not in the MIME-treated muscle (red desmin labeling detects viable muscle fibers). In the host TA muscle treated with MIME and BaCl 2 injection, the donor-cell-derived myogenesis is evident from the presence of many desmin(+) muscle fibers that show no detectable GFP signal ( Figure  3C-D, 3 C'-D' ). Chimeric muscle fibers arising from the likely fusion of the host and donor myogenic cells can be detected by the low to moderate levels of GFP fluorescence exhibited by these fibers. Numerous chimeric fibers appear across the entire diameter of the TA muscle suggesting that the donor SCs are capable of migrating several hundreds of microns within the epimysium of the host muscle. Quantitation of GFP+ fibers is shown in Figure 3E . Figure 4 shows high magnification images of serial cross sections of an entire MIME+BaCl 2 treated TA muscle. 
